Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex

Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) corte...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 40; no. 11; pp. 2526 - 2535
Main Authors Scofield, Michael D, Trantham-Davidson, Heather, Schwendt, Marek, Leong, Kah-Chung, Peters, Jamie, See, Ronald E, Reichel, Carmela M
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.10.2015
Subjects
Online AccessGet full text
ISSN0893-133X
1740-634X
DOI10.1038/npp.2015.99

Cover

Abstract Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl-D-aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment.
AbstractList Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl- D -aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment.
Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl-D-aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment.
Author Scofield, Michael D
Reichel, Carmela M
Schwendt, Marek
Leong, Kah-Chung
Peters, Jamie
Trantham-Davidson, Heather
See, Ronald E
Author_xml – sequence: 1
  givenname: Michael D
  surname: Scofield
  fullname: Scofield, Michael D
– sequence: 2
  givenname: Heather
  surname: Trantham-Davidson
  fullname: Trantham-Davidson, Heather
– sequence: 3
  givenname: Marek
  surname: Schwendt
  fullname: Schwendt, Marek
– sequence: 4
  givenname: Kah-Chung
  surname: Leong
  fullname: Leong, Kah-Chung
– sequence: 5
  givenname: Jamie
  surname: Peters
  fullname: Peters, Jamie
– sequence: 6
  givenname: Ronald E
  surname: See
  fullname: See, Ronald E
– sequence: 7
  givenname: Carmela M
  surname: Reichel
  fullname: Reichel, Carmela M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25865928$$D View this record in MEDLINE/PubMed
BookMark eNptkl1rFDEUhoNU7Hb1ynsJeCPIrMlkZya5EcraqrB-oBV6FzKZM7spmWRMMqX1Z_iLzdhWtHh1Auc5b97zcYQOnHeA0FNKVpQw_sqN46oktFoJ8QAtaLMmRc3W5wdoQbhgBWXs_BAdxXhBMtTU_BE6LCteV6LkC_TzVBk7BcDJ4y-g_c6ZH4A_-kuw6RqrPkHAJ1cJXAcd_gBpr4ZxD0kNxgH-CrYvjrv8NjEFlYx3WSRONkXcBz_grY8R-z5HtyvOIAz4DYwBYpxJ43DaA_4MwYS9ccrijQ8Jrh6jh72yEZ7cxiX6dnpytnlXbD-9fb853ha6angqOIG2pWWvy74mjDYaWkKhLUsmVNewjtXVWvFG1T3ouqRV1XUtEa2qSN1WOueX6PWN7ji1A3QaXO7ByjGYQYVr6ZWR_2ac2cudv5TrqhYi_7lEL24Fgv8-QUxyMFGDtcqBn6KkTVnSumFkRp_fQy_8FHLPM0WJ4JxQmqlnfzv6Y-VuXRmgN4AOebIBeqlN-j33bNBYSYmcT0Lmk5DzSUghcs3LezV3sv-jfwG-Druj
CODEN NEROEW
CitedBy_id crossref_primary_10_1007_s00429_016_1322_x
crossref_primary_10_1016_j_neuroscience_2019_03_040
crossref_primary_10_1016_j_addicn_2024_100181
crossref_primary_10_1038_npp_2015_283
crossref_primary_10_1371_journal_pone_0218934
crossref_primary_10_1016_j_pbb_2020_173058
crossref_primary_10_1111_ejn_13159
crossref_primary_10_1016_j_neubiorev_2016_07_020
crossref_primary_10_1016_j_nlm_2021_107464
crossref_primary_10_1038_s41386_022_01371_9
crossref_primary_10_1016_j_neuropharm_2023_109711
crossref_primary_10_1101_lm_046797_117
crossref_primary_10_1111_adb_12881
crossref_primary_10_3390_brainsci14030258
crossref_primary_10_1124_jpet_116_238501
crossref_primary_10_1101_lm_048488_118
crossref_primary_10_1016_j_pbb_2018_09_007
crossref_primary_10_1016_j_pharmthera_2021_107831
crossref_primary_10_1007_s10571_023_01323_x
crossref_primary_10_1007_s12272_017_0897_y
crossref_primary_10_1016_j_neuropharm_2017_11_034
crossref_primary_10_1155_2017_7903918
Cites_doi 10.1016/j.biopsych.2011.10.024
10.1007/s00213-010-1828-5
10.1038/nn1713
10.1016/j.neuropharm.2013.04.013
10.1073/pnas.0607973103
10.1038/npp.2011.276
10.1038/nn.3154
10.1523/JNEUROSCI.5289-06.2007
10.1038/npp.2012.179
10.1038/81823
10.1016/j.bbr.2009.12.036
10.1016/S0022-3565(24)37138-1
10.1016/j.jsat.2009.03.004
10.1016/j.neuron.2008.04.006
10.1523/JNEUROSCI.4447-07.2008
10.1016/j.neuron.2008.02.022
10.1038/nrn2572
10.1038/35049064
10.1038/72093
10.1038/nn1914
10.1038/nn.2250
10.1002/hipo.20178
10.1523/JNEUROSCI.0623-13.2014
10.1523/JNEUROSCI.1697-04.2004
10.1523/JNEUROSCI.1935-08.2008
10.1523/JNEUROSCI.6413-10.2011
10.1002/hipo.10049
10.1523/JNEUROSCI.4307-14.2015
10.1037/a0013829
10.1007/s11065-007-9031-0
10.1038/nn.2300
10.1111/adb.12061
10.1007/s00213-008-1187-7
10.1016/S0306-4522(98)00764-7
10.1371/journal.pone.0034299
10.1016/j.pneurobio.2011.03.002
10.1016/j.tins.2012.05.006
10.1002/syn.20471
10.1016/j.jsat.2004.03.011
10.1523/JNEUROSCI.5239-10.2011
10.1016/j.drugalcdep.2013.09.018
10.1016/j.neuropharm.2011.11.003
10.1038/npp.2010.212
10.1124/pr.112.007054
ContentType Journal Article
Copyright Copyright Nature Publishing Group Oct 2015
Copyright © 2015 American College of Neuropsychopharmacology 2015 American College of Neuropsychopharmacology
Copyright_xml – notice: Copyright Nature Publishing Group Oct 2015
– notice: Copyright © 2015 American College of Neuropsychopharmacology 2015 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
5PM
DOI 10.1038/npp.2015.99
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database (Proquest)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList
ProQuest One Psychology
MEDLINE
Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Novelty after extended methamphetamine
EISSN 1740-634X
EndPage 2535
ExternalDocumentID PMC4569960
3803743581
25865928
10_1038_npp_2015_99
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: DA007288
– fundername: NIDA NIH HHS
  grantid: T32 DA007288
– fundername: NIDA NIH HHS
  grantid: DA033049
– fundername: NCRR NIH HHS
  grantid: C06 RR015455
– fundername: NIDA NIH HHS
  grantid: R01 DA033049
GroupedDBID ---
-DZ
-Q-
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDB
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
MK0
NQJWS
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
--K
1B1
53G
5VS
AAEDT
AALRI
AAQFI
AAQXK
AAXUO
ABMAC
ABWVN
ACIUM
ACRPL
ADMUD
ADNMO
CAG
CGR
COF
CUY
CVF
ECM
EIF
FEDTE
FGOYB
HVGLF
IHE
LGEZI
LOTEE
M41
NADUK
NPM
NQ-
NXXTH
R2-
RIG
RNS
RPZ
SEW
SSZ
ZKB
3V.
7TK
7XB
8FE
8FH
8FK
ABRTQ
K9.
LK8
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
PUEGO
5PM
ID FETCH-LOGICAL-c578t-80ebb12fc2f60317ceb01eb2239ad73d3654a87a6fec62155ddb09ba506b5c3d3
IEDL.DBID 7X7
ISSN 0893-133X
IngestDate Thu Aug 21 14:10:49 EDT 2025
Fri Sep 05 07:57:40 EDT 2025
Fri Jul 25 09:12:55 EDT 2025
Thu Apr 03 07:06:22 EDT 2025
Sun Jul 06 05:08:45 EDT 2025
Thu Apr 24 23:09:46 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c578t-80ebb12fc2f60317ceb01eb2239ad73d3654a87a6fec62155ddb09ba506b5c3d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/npp201599.pdf
PMID 25865928
PQID 1710988011
PQPubID 33935
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4569960
proquest_miscellaneous_1722167300
proquest_journals_1710988011
pubmed_primary_25865928
crossref_citationtrail_10_1038_npp_2015_99
crossref_primary_10_1038_npp_2015_99
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2015
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References EC Beattie (BFnpp201599_CR6) 2000; 3
M Schwendt (BFnpp201599_CR37) 2012; 7
GR Barker (BFnpp201599_CR4) 2011; 31
CM Reichel (BFnpp201599_CR34) 2010; 210
GR Barker (BFnpp201599_CR3) 2008; 28
YS Lee (BFnpp201599_CR19) 2009; 10
M Martin (BFnpp201599_CR23) 2006; 9
PV Massey (BFnpp201599_CR25) 2008; 28
LA Knackstedt (BFnpp201599_CR17) 2014; 19
PV Massey (BFnpp201599_CR24) 2004; 24
G Fischer (BFnpp201599_CR11) 1997; 283
Z Ziakopoulos (BFnpp201599_CR44) 1999; 92
UD McCann (BFnpp201599_CR26) 2008; 62
BP Staresina (BFnpp201599_CR40) 2012; 15
AC Dean (BFnpp201599_CR9) 2013; 38
MM Albasser (BFnpp201599_CR1) 2009; 123
A Ennaceur (BFnpp201599_CR10) 2010; 215
K Cho (BFnpp201599_CR8) 2000; 3
CC Huang (BFnpp201599_CR15) 2011; 31
YM Kupchik (BFnpp201599_CR18) 2012; 71
K Moussawi (BFnpp201599_CR28) 2009; 12
JC Scott (BFnpp201599_CR38) 2007; 17
CM Reichel (BFnpp201599_CR31) 2014; 134
CM Reichel (BFnpp201599_CR32) 2012; 62
S Griffiths (BFnpp201599_CR12) 2008; 58
M Pihlajamaki (BFnpp201599_CR30) 2003; 13
MW Brown (BFnpp201599_CR7) 2001; 2
S Wood (BFnpp201599_CR43) 2014; 66
H Trantham-Davidson (BFnpp201599_CR41) 2014; 34
CL Hart (BFnpp201599_CR13) 2012; 37
L Malkova (BFnpp201599_CR20) 2015; 35
AL Barth (BFnpp201599_CR5) 2008; 58
SL Simon (BFnpp201599_CR39) 2004; 27
GR Barker (BFnpp201599_CR2) 2007; 27
D Montaldi (BFnpp201599_CR27) 2006; 16
JL Rogers (BFnpp201599_CR35) 2008; 199
R Salo (BFnpp201599_CR36) 2009; 37
AH Hawasli (BFnpp201599_CR14) 2007; 10
CM Reichel (BFnpp201599_CR33) 2011; 36
LM Mao (BFnpp201599_CR21) 2009; 12
EC Warburton (BFnpp201599_CR42) 2013; 74
J Kealy (BFnpp201599_CR16) 2011; 93
JF Marshall (BFnpp201599_CR22) 2012; 35
RA O'Neill (BFnpp201599_CR29) 2006; 103
24344115 - Pharmacol Rev. 2014;66(1):193-221
23710649 - Addict Biol. 2014 Jan;19(1):87-101
10649570 - Nat Neurosci. 2000 Feb;3(2):150-6
15223095 - J Subst Abuse Treat. 2004 Jul;27(1):59-66
20060020 - Behav Brain Res. 2010 Dec 31;215(2):244-54
11253359 - Nat Rev Neurosci. 2001 Jan;2(1):51-61
17992686 - Synapse. 2008 Feb;62(2):91-100
19349975 - Nat Neurosci. 2009 May;12(5):602-10
21411660 - J Neurosci. 2011 Mar 16;31(11):4194-203
21150906 - Neuropsychopharmacology. 2011 Mar;36(4):782-92
22709631 - Trends Neurosci. 2012 Sep;35(9):536-45
10408597 - Neuroscience. 1999;92(2):459-72
17053065 - Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16153-8
21775615 - J Neurosci. 2011 Jul 20;31(29):10721-31
15356193 - J Neurosci. 2004 Sep 8;24(36):7821-8
18650332 - J Neurosci. 2008 Jul 23;28(30):7548-54
19339145 - J Subst Abuse Treat. 2009 Oct;37(3):292-7
18439404 - Neuron. 2008 Apr 24;58(2):186-94
19170436 - Behav Neurosci. 2009 Feb;123(1):115-24
16634088 - Hippocampus. 2006;16(5):504-20
22479593 - PLoS One. 2012;7(3):e34299
18337414 - J Neurosci. 2008 Mar 12;28(11):2837-44
17694436 - Neuropsychol Rev. 2007 Sep;17(3):275-97
22751037 - Nat Neurosci. 2012 Aug;15(8):1167-73
25810533 - J Neurosci. 2015 Mar 25;35(12):5043-50
24599469 - J Neurosci. 2014 Mar 5;34(10):3706-18
19136971 - Nat Neurosci. 2009 Feb;12(2):182-9
20352413 - Psychopharmacology (Berl). 2010 Jun;210(3):337-46
17360918 - J Neurosci. 2007 Mar 14;27(11):2948-57
18493748 - Psychopharmacology (Berl). 2008 Sep;199(4):615-24
22115899 - Neuropharmacology. 2012 Feb;62(2):1119-26
21420466 - Prog Neurobiol. 2011 Apr;93(4):522-48
22089317 - Neuropsychopharmacology. 2012 Feb;37(3):586-608
22948978 - Neuropsychopharmacology. 2013 Jan;38(2):259-74
12625459 - Hippocampus. 2003;13(1):67-80
9400004 - J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92
19153576 - Nat Rev Neurosci. 2009 Feb;10(2):126-40
16732275 - Nat Neurosci. 2006 Jul;9(7):868-9
18439398 - Neuron. 2008 Apr 24;58(2):159-61
24120858 - Drug Alcohol Depend. 2014 Jan 1;134:115-22
11100150 - Nat Neurosci. 2000 Dec;3(12):1291-300
17529984 - Nat Neurosci. 2007 Jul;10(7):880-6
22137594 - Biol Psychiatry. 2012 Jun 1;71(11):978-86
23665343 - Neuropharmacology. 2013 Nov;74:41-7
References_xml – volume: 71
  start-page: 978
  year: 2012
  ident: BFnpp201599_CR18
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2011.10.024
– volume: 210
  start-page: 337
  year: 2010
  ident: BFnpp201599_CR34
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-010-1828-5
– volume: 9
  start-page: 868
  year: 2006
  ident: BFnpp201599_CR23
  publication-title: Nat Neurosci
  doi: 10.1038/nn1713
– volume: 74
  start-page: 41
  year: 2013
  ident: BFnpp201599_CR42
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2013.04.013
– volume: 103
  start-page: 16153
  year: 2006
  ident: BFnpp201599_CR29
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0607973103
– volume: 37
  start-page: 586
  year: 2012
  ident: BFnpp201599_CR13
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.276
– volume: 15
  start-page: 1167
  year: 2012
  ident: BFnpp201599_CR40
  publication-title: Nat Neurosci
  doi: 10.1038/nn.3154
– volume: 27
  start-page: 2948
  year: 2007
  ident: BFnpp201599_CR2
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5289-06.2007
– volume: 38
  start-page: 259
  year: 2013
  ident: BFnpp201599_CR9
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2012.179
– volume: 3
  start-page: 1291
  year: 2000
  ident: BFnpp201599_CR6
  publication-title: Nat Neurosci
  doi: 10.1038/81823
– volume: 215
  start-page: 244
  year: 2010
  ident: BFnpp201599_CR10
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2009.12.036
– volume: 283
  start-page: 1285
  year: 1997
  ident: BFnpp201599_CR11
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(24)37138-1
– volume: 37
  start-page: 292
  year: 2009
  ident: BFnpp201599_CR36
  publication-title: J Subst Abuse Treat
  doi: 10.1016/j.jsat.2009.03.004
– volume: 58
  start-page: 159
  year: 2008
  ident: BFnpp201599_CR5
  publication-title: Neuron
  doi: 10.1016/j.neuron.2008.04.006
– volume: 28
  start-page: 2837
  year: 2008
  ident: BFnpp201599_CR3
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4447-07.2008
– volume: 58
  start-page: 186
  year: 2008
  ident: BFnpp201599_CR12
  publication-title: Neuron
  doi: 10.1016/j.neuron.2008.02.022
– volume: 10
  start-page: 126
  year: 2009
  ident: BFnpp201599_CR19
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn2572
– volume: 2
  start-page: 51
  year: 2001
  ident: BFnpp201599_CR7
  publication-title: Nat Rev Neurosci
  doi: 10.1038/35049064
– volume: 3
  start-page: 150
  year: 2000
  ident: BFnpp201599_CR8
  publication-title: Nat Neurosci
  doi: 10.1038/72093
– volume: 10
  start-page: 880
  year: 2007
  ident: BFnpp201599_CR14
  publication-title: Nat Neurosci
  doi: 10.1038/nn1914
– volume: 12
  start-page: 182
  year: 2009
  ident: BFnpp201599_CR28
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2250
– volume: 16
  start-page: 504
  year: 2006
  ident: BFnpp201599_CR27
  publication-title: Hippocampus
  doi: 10.1002/hipo.20178
– volume: 34
  start-page: 3706
  year: 2014
  ident: BFnpp201599_CR41
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.0623-13.2014
– volume: 24
  start-page: 7821
  year: 2004
  ident: BFnpp201599_CR24
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1697-04.2004
– volume: 28
  start-page: 7548
  year: 2008
  ident: BFnpp201599_CR25
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1935-08.2008
– volume: 31
  start-page: 10721
  year: 2011
  ident: BFnpp201599_CR4
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.6413-10.2011
– volume: 13
  start-page: 67
  year: 2003
  ident: BFnpp201599_CR30
  publication-title: Hippocampus
  doi: 10.1002/hipo.10049
– volume: 35
  start-page: 5043
  year: 2015
  ident: BFnpp201599_CR20
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4307-14.2015
– volume: 123
  start-page: 115
  year: 2009
  ident: BFnpp201599_CR1
  publication-title: Behav Neurosci
  doi: 10.1037/a0013829
– volume: 17
  start-page: 275
  year: 2007
  ident: BFnpp201599_CR38
  publication-title: Neuropsychol Rev
  doi: 10.1007/s11065-007-9031-0
– volume: 12
  start-page: 602
  year: 2009
  ident: BFnpp201599_CR21
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2300
– volume: 19
  start-page: 87
  year: 2014
  ident: BFnpp201599_CR17
  publication-title: Addict Biol
  doi: 10.1111/adb.12061
– volume: 199
  start-page: 615
  year: 2008
  ident: BFnpp201599_CR35
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-008-1187-7
– volume: 92
  start-page: 459
  year: 1999
  ident: BFnpp201599_CR44
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(98)00764-7
– volume: 7
  start-page: e34299
  year: 2012
  ident: BFnpp201599_CR37
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0034299
– volume: 93
  start-page: 522
  year: 2011
  ident: BFnpp201599_CR16
  publication-title: Prog Neurobiol
  doi: 10.1016/j.pneurobio.2011.03.002
– volume: 35
  start-page: 536
  year: 2012
  ident: BFnpp201599_CR22
  publication-title: Trends in neurosciences
  doi: 10.1016/j.tins.2012.05.006
– volume: 62
  start-page: 91
  year: 2008
  ident: BFnpp201599_CR26
  publication-title: Synapse
  doi: 10.1002/syn.20471
– volume: 27
  start-page: 59
  year: 2004
  ident: BFnpp201599_CR39
  publication-title: J Subst Abuse Treat
  doi: 10.1016/j.jsat.2004.03.011
– volume: 31
  start-page: 4194
  year: 2011
  ident: BFnpp201599_CR15
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5239-10.2011
– volume: 134
  start-page: 115
  year: 2014
  ident: BFnpp201599_CR31
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2013.09.018
– volume: 62
  start-page: 1119
  year: 2012
  ident: BFnpp201599_CR32
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2011.11.003
– volume: 36
  start-page: 782
  year: 2011
  ident: BFnpp201599_CR33
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2010.212
– volume: 66
  start-page: 193
  year: 2014
  ident: BFnpp201599_CR43
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.112.007054
– reference: 17529984 - Nat Neurosci. 2007 Jul;10(7):880-6
– reference: 19339145 - J Subst Abuse Treat. 2009 Oct;37(3):292-7
– reference: 23665343 - Neuropharmacology. 2013 Nov;74:41-7
– reference: 18439404 - Neuron. 2008 Apr 24;58(2):186-94
– reference: 21420466 - Prog Neurobiol. 2011 Apr;93(4):522-48
– reference: 18337414 - J Neurosci. 2008 Mar 12;28(11):2837-44
– reference: 19136971 - Nat Neurosci. 2009 Feb;12(2):182-9
– reference: 15223095 - J Subst Abuse Treat. 2004 Jul;27(1):59-66
– reference: 17694436 - Neuropsychol Rev. 2007 Sep;17(3):275-97
– reference: 22709631 - Trends Neurosci. 2012 Sep;35(9):536-45
– reference: 19153576 - Nat Rev Neurosci. 2009 Feb;10(2):126-40
– reference: 22948978 - Neuropsychopharmacology. 2013 Jan;38(2):259-74
– reference: 20352413 - Psychopharmacology (Berl). 2010 Jun;210(3):337-46
– reference: 24120858 - Drug Alcohol Depend. 2014 Jan 1;134:115-22
– reference: 22137594 - Biol Psychiatry. 2012 Jun 1;71(11):978-86
– reference: 17992686 - Synapse. 2008 Feb;62(2):91-100
– reference: 23710649 - Addict Biol. 2014 Jan;19(1):87-101
– reference: 19170436 - Behav Neurosci. 2009 Feb;123(1):115-24
– reference: 18493748 - Psychopharmacology (Berl). 2008 Sep;199(4):615-24
– reference: 22479593 - PLoS One. 2012;7(3):e34299
– reference: 21150906 - Neuropsychopharmacology. 2011 Mar;36(4):782-92
– reference: 20060020 - Behav Brain Res. 2010 Dec 31;215(2):244-54
– reference: 18650332 - J Neurosci. 2008 Jul 23;28(30):7548-54
– reference: 10649570 - Nat Neurosci. 2000 Feb;3(2):150-6
– reference: 12625459 - Hippocampus. 2003;13(1):67-80
– reference: 22089317 - Neuropsychopharmacology. 2012 Feb;37(3):586-608
– reference: 24599469 - J Neurosci. 2014 Mar 5;34(10):3706-18
– reference: 15356193 - J Neurosci. 2004 Sep 8;24(36):7821-8
– reference: 9400004 - J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92
– reference: 18439398 - Neuron. 2008 Apr 24;58(2):159-61
– reference: 21411660 - J Neurosci. 2011 Mar 16;31(11):4194-203
– reference: 22115899 - Neuropharmacology. 2012 Feb;62(2):1119-26
– reference: 11253359 - Nat Rev Neurosci. 2001 Jan;2(1):51-61
– reference: 19349975 - Nat Neurosci. 2009 May;12(5):602-10
– reference: 25810533 - J Neurosci. 2015 Mar 25;35(12):5043-50
– reference: 17360918 - J Neurosci. 2007 Mar 14;27(11):2948-57
– reference: 16732275 - Nat Neurosci. 2006 Jul;9(7):868-9
– reference: 17053065 - Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16153-8
– reference: 21775615 - J Neurosci. 2011 Jul 20;31(29):10721-31
– reference: 11100150 - Nat Neurosci. 2000 Dec;3(12):1291-300
– reference: 10408597 - Neuroscience. 1999;92(2):459-72
– reference: 16634088 - Hippocampus. 2006;16(5):504-20
– reference: 22751037 - Nat Neurosci. 2012 Aug;15(8):1167-73
– reference: 24344115 - Pharmacol Rev. 2014;66(1):193-221
SSID ssj0015768
Score 2.2940924
Snippet Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2526
SubjectTerms Abstinence
Addictions
Amphetamine-Related Disorders - drug therapy
Amphetamine-Related Disorders - physiopathology
Animals
Central Nervous System Stimulants - administration & dosage
Cognitive ability
Cycloserine - pharmacology
Excitatory Amino Acid Agents - pharmacology
Laboratory animals
Long-Term Synaptic Depression - drug effects
Long-Term Synaptic Depression - physiology
Male
Memory
Memory Disorders - chemically induced
Memory Disorders - physiopathology
Methamphetamine
Methamphetamine - administration & dosage
Neurosciences
Original
Phenols - pharmacology
Physiology
Piperidines - pharmacology
Rats, Sprague-Dawley
Receptors, N-Methyl-D-Aspartate - agonists
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate - metabolism
Recognition (Psychology) - drug effects
Recognition (Psychology) - physiology
Self Administration
Tissue Culture Techniques
Title Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex
URI https://www.ncbi.nlm.nih.gov/pubmed/25865928
https://www.proquest.com/docview/1710988011
https://www.proquest.com/docview/1722167300
https://pubmed.ncbi.nlm.nih.gov/PMC4569960
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLVgkxAvCDo-AmMy0rQHNLM433lCY7SaEK2q0Ul9i-zYZpUypywpovwMfjHXjputgHhpH-wmqe69uce-x-cidKhizlMVRkQIEZAIcizJMiZICJ8qpipKraTQeJKcX0af5vHcbbg1jla5eSfaF7WoS7NHfkINaRCcjdL3y2_EdI0y1VXXQuM-2rXSZeDP6bxfcFGDpS2KzEMCa7G5O5_nh9mJXhqxShq_s6KvdzLSXzDzT7bknfQzeoweOdyITztDP0H3pB6gvVMNa-brNT7Clslpt8gH6MHYFcwH6GjaSVOvj_Hs9qRVc2x_0YtWr_fQrxFbGIY6bmt80ZGKfko8qb_Lql1j20kcD92GOR7L9oqBG8iWXcNt8BdZKbItwwsXaVZV22BzfgV_hj-OawXf-iuZQTLAHzcMXI0XGgMKxVOIhRvTzbvCZ4YB_OMpuhwNZ2fnxPVrICXEfQvJTnJOA1UGyvSuTkvJfQor9yDMmUhDESZxxLKUJUqWCUCNWAju55zFfsLjEsafoR1da_kCYQU5lAouQ8FFFPg5g0szv-RS0kwAZPTQ243NitKJmZueGlVhi-phVoCBC2PgIs89dNhPXnYaHv-etr8xfuECuSlu3c5Db_phCEFTV2Fa1iszJwhoYoT_PfS885X-PkGcmcJ15qF0y4v6CUbee3tEL66szDdAWyOd8_L_j_UKPTTP3_EL99FOe7OSrwEntfzABsMB2v0wnEwvfgNPyRlB
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuCFIeKQUWqfSAaur344BQaROlNImikkq5ubvedRsptUPjAOFn8EP4jcz41QYQt17sw67XtmZ2Z3bnm28AtmNHCC-2bE1KaWo22ljN97nULLzGjhHbXk4p1B-43VP709gZr8GvKheGYJXVmpgv1DKN6Ix8zyDQICqbYXyYfdGoahRFV6sSGoVaHKvlN9yyzd8fHaJ835hmpz066GplVQEtQu3McElWQhhmHJkxVVj2IiV0A_eXphVw6VnSch2b-x53YxW5aBAdKYUeCO7ornAibMdx78C6TRmtDVj_2B4MT-q4BXnvud8aWBru_sZlRqBu-XvJjOgxDeddTjN7wwb-5dj-ic-8YfA6D-FB6amy_UK1HsGaSpqwsZ_gLv1yyXZYjh3ND-WbcLdfhuibsDMsyLCXu2x0nds1382fqGmylxvws8MnhIlnWcpOChjTD8UG6Vc1zZYsr13O2uURPeur7IKj4qmMX-Jr2Gc1jbVV4l8cZL6YZnNGGTOshz_O0hjvybk2QvPDDivMb8ImCUO_lw1x9l1R_fApOyDM8ffHcHorsnwCjSRN1DNgMVptQwplSSFtUw84Ds31SChl-BKd1Ba8rWQWRiV9OlXxmIZ5GN_yQxRwSAIOg6AF23XnWcEa8u9uW5Xww3LpmIfXit6C13UzTnqK5PBEpQvqY5qGS6UGWvC00JX6PabjU6jcb4G3okV1ByIUX21JJhc5sTg600TWs_n_z3oF97qjfi_sHQ2On8N9-pcC3bgFjexqoV6gl5aJl-XUYHB227PxN5knVrA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIlVcUEl5hBYwUukBdcl633tAqGoatbSJIkil3BZ7bdNI6W5oNkD4Gfwcfh1j76MNIG69JAc73qxmxjPj-fwNwK7yOQ-V61lCCMfy0MdaUcSE5eKn8qnyQkMp1B8Ex-fe-7E_XoNf9V0YDaus90SzUYs81WfkHapBg6hslHZUBYsYdnvvZl8s3UFKV1rrdhqlipzK5TdM3-ZvT7oo61eO0zsaHR5bVYcBK0VNLXB7lpxTR6WO0t2Ww1Rym2Ku6bgxE6Er3MD3WBSyQMk0QOfoC8HtmDPfDrif4jiuewfuhi5GVWhL4bhJ9qiO400EG7sW5oHj6m6g7UadbKaJMqn_xhDO3vCGf4W4fyI1b7i-3ibcr2JWclAq2QNYk1kLtg4yzNcvl2SPGBSpOZ5vwUa_Kta3YG9Y0mIv98no-pbXfN_8oiHMXm7Bzx6baHQ8KXLyoQQ0_ZBkkH-V02JJTBdzclQd1pO-LC4YqqAs2CU-hnyUU2WtUgDjIvPFtJgTfXeGnOGLk1zhd_bZGqEjIt0a_ZuRSUYwAiZDtMMr3Ul8Sg41-vj7Qzi_FUk-gvUsz-QTIAr9NxVcuoILz7FjhkszO-VS0khguNqG17XMkrQiUtf9PKaJKei7UYICTrSAkzhuw24zeVbyh_x72k4t_KTaRObJtcq34WUzjOavazosk_lCz3EcGuimA214XOpK8xzHj3TRPGpDuKJFzQRNLb46kk0uDMU4htWatufp___WC9hAG0zOTgan23BPv0oJc9yB9eJqIZ9huFbw58YuCHy6bUP8DUfzWXc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Failure+to+Recognize+Novelty+after+Extended+Methamphetamine+Self-Administration+Results+from+Loss+of+Long-Term+Depression+in+the+Perirhinal+Cortex&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Scofield%2C+Michael+D&rft.au=Trantham-Davidson%2C+Heather&rft.au=Schwendt%2C+Marek&rft.au=Leong%2C+Kah-Chung&rft.date=2015-10-01&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=40&rft.issue=11&rft.spage=2526&rft.epage=2535&rft_id=info:doi/10.1038%2Fnpp.2015.99&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_npp_2015_99
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon